Celldex Therapeutics buy Rouvenhey
Start price
26.02.20
/
50%
€2.27
Target price
04.11.21
€3.00
Performance (%)
566.52%
End price
05.11.20
€15.13
Summary
This prediction ended on 05.11.20 with a price of €15.13. The BUY prediction by Rouvenhey for Celldex Therapeutics saw massive gains of 566.52%. Rouvenhey has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celldex Therapeutics | 14.315% | 14.315% | 99.648% | -0.176% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % | 49,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % | 82,05 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % | 60,62 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % | 59,66 % |